Johnson & Johnson Vision increases range of Abiliti overnight contact lenses
Click Here to Manage Email Alerts
Johnson & Johnson Vision announced that the FDA approved a parameter expansion for Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management from 4 D to 6 D.
“By expanding the parameters for Abiliti Overnight lenses, it creates more opportunities for eye care professionals to reach even more patients,” Chandra Mickles, OD, MSc, FAAO, FSLS, North America professional education lead, myopia, Johnson & Johnson Vision said in the release. “The expansion of treatment options comes at a critical time as myopia rates continue to rise among children. At Johnson & Johnson Vision we remain committed to changing the trajectory of myopia with evidence-based strategies and professional support.”
Abiliti contacts are orthokeratology lenses worn overnight and designed to reduce refractive error, possibly eliminating the patient’s need for glasses or contacts during the day.
In addition, FitAbiliti, an accompanying software, assists eye care professionals by recommending a lens, with a first fit success rate of approximately 90%, according to the press release.
Abiliti lenses are available nationwide for either myopia management or myopia management for astigmatism. For each purchase of an Abiliti product, Johnson & Johnson Vision will provide a free comprehensive eye health exam for a child in need through Sight for Kids, the company said.
Read more about
Click Here to Manage Email Alerts